Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if this combination of chemotherapy plus radiation
therapy and immunotherapy (with bevacizumab) expands treatment options for patients with
non-small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
SCRI Development Innovations, LLC
Collaborators:
Eli Lilly and Company Genentech, Inc.
Treatments:
Bevacizumab Carboplatin Folic Acid Hydroxocobalamin Pemetrexed Vitamin B 12 Vitamin B Complex Vitamins